Summary
The Latvian Institute of Organic Synthesis (LIOS) is in great need to enhance its scientific performance and this could be accomplished through stronger international collaboration within the defined National RIS3 specialization in biomedicine. Latvia is performing well below the EU-average in terms of research excellence and innovation scoreboard. The FAT4BRAIN project builds cooperation between LIOS from the Widening region and world leading partners in translational neuropharmacology (Uppsala University), metabolism and neuropsychiatric imaging research (Eberhard Karls University Tuebingen) as well as innovative mitochondria research company (Oroboros Instruments). The aim of FAT4BRAIN is to establish a network of excellence focused on the pivotal and common role of fatty acid metabolism in the development of neurological disorders, an issue of utmost biomedical and societal interest. FAT4BRAIN will use a multidisciplinary, functional pharmacology approach to promote cutting-edge research in this field. A comprehensive set of activities including workshops, expert meetings and dedicated trainings for early-stage researchers will enhance knowledge-bridging and networking. FAT4BRAIN activities will specifically focus on strengthening capacities in areas that need improvement at LIOS, using the internationally-leading partners’ excellence and experience. Dissemination of results to the research community, industry partners and public through presentations at conferences, media outputs as well as high impact publications will be facilitated by the partners’ extraordinary reputation and high-impact profile. Importantly, the research excellence of the partnering institutions together with the targeted activities of FAT4BRAIN will help LIOS to improve their own research profile by increasing methodological capacities in preclinical and translational research and scientific output in terms of publications of highest quality and impact.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/857394 |
| Start date: | 01-11-2019 |
| End date: | 30-04-2023 |
| Total budget - Public funding: | 799 406,25 Euro - 799 406,00 Euro |
Cordis data
Original description
The Latvian Institute of Organic Synthesis (LIOS) is in great need to enhance its scientific performance and this could be accomplished through stronger international collaboration within the defined National RIS3 specialization in biomedicine. Latvia is performing well below the EU-average in terms of research excellence and innovation scoreboard. The FAT4BRAIN project builds cooperation between LIOS from the Widening region and world leading partners in translational neuropharmacology (Uppsala University), metabolism and neuropsychiatric imaging research (Eberhard Karls University Tuebingen) as well as innovative mitochondria research company (Oroboros Instruments). The aim of FAT4BRAIN is to establish a network of excellence focused on the pivotal and common role of fatty acid metabolism in the development of neurological disorders, an issue of utmost biomedical and societal interest. FAT4BRAIN will use a multidisciplinary, functional pharmacology approach to promote cutting-edge research in this field. A comprehensive set of activities including workshops, expert meetings and dedicated trainings for early-stage researchers will enhance knowledge-bridging and networking. FAT4BRAIN activities will specifically focus on strengthening capacities in areas that need improvement at LIOS, using the internationally-leading partners’ excellence and experience. Dissemination of results to the research community, industry partners and public through presentations at conferences, media outputs as well as high impact publications will be facilitated by the partners’ extraordinary reputation and high-impact profile. Importantly, the research excellence of the partnering institutions together with the targeted activities of FAT4BRAIN will help LIOS to improve their own research profile by increasing methodological capacities in preclinical and translational research and scientific output in terms of publications of highest quality and impact.Status
CLOSEDCall topic
WIDESPREAD-03-2018Update Date
17-05-2024
Images
No images available.
Geographical location(s)
